Williams Donald Allen
SEC Form 4 insider trading activity
Williams Donald Allen has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Oct 5, 2026.
On the most recent filing, Williams Donald Allen is listed as Director at PALISADE BIO, INC. Inside the rolling window, Williams Donald Allen reported 4 open-market purchases totaling $47K in PALI and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 PALI shares on Oct 2, 2026, worth $15K.
Companies traded
Other insiders at PALI
Insider Buying
$47K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Williams Donald Allen made?
Williams Donald Allen has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Williams Donald Allen trade?
Williams Donald Allen has filed SEC Form 4 disclosures for 1 company, including PALI.
When was Williams Donald Allen's most recent SEC Form 4 filing?
Williams Donald Allen's most recent SEC Form 4 filing on Tracefour is dated Oct 5, 2026.
What is Williams Donald Allen's total buy and sell value in the current window?
Inside the rolling retention window, Williams Donald Allen bought $47K and sold $0 based on SEC Form 4 filings.
What was Williams Donald Allen's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 PALI shares on 2026-10-02, worth $15K, per SEC Form 4 filings.